Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients — ISCIW  

Inflammation Clinical Trial

Official title: Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients

Status Completed

Clinical Trial Summary

This study intents to determine who will benefit from an intensive brief stress coping intervention week (ISCIW) as secondary prevention for real world affective disorder patients.

Clinical Trial Description

Affective disorders are associated with a substantial personal and socio-economic burden. This study evaluates an intensive brief stress-coping intervention week (ISCIW) as feasible follow-up treatment for real world patients who suffer from this highly prevalent and chronic stress-related disorders. Stress-associated blood (Interleukin-6, Homocystein, Myeloperoxidase), saliva cortisol and psychosocial screening parameters will be analyzed to determine who will benefit from the ISCIW. All patients were identified in a preventive medical screening before pre-treatment for at least three month as outpatient and the following inclusion to the follow-up ISCIW-trial at the Health and Prevention Center, Sanatorium Hera, Vienna, Austria. For the three planed groups and interventions see interventions and arms. ;

Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Affective Disorders
• Anxiety Disorders
• Disease
• Emotions
• Inflammation
• Mood Disorders
• Oxidative Stress
• Psychological Stress
• Stress, Psychological

• NCT number: NCT02752295
• Study type: Interventional
• Source: Medical University of Vienna
• Status: Completed
• Phase: N/A
• Start date: May 2015
• Completion date: July 2016